Genvor Joins B2i Digital Platform to Expand Investor Engagement for AI-Driven Agricultural Solutions
TL;DR
Genvor's AI-accelerated peptide platform offers agricultural companies a competitive edge by reducing crop losses through sustainable biological solutions that outperform traditional methods.
Genvor's BioCypher Algorithm leverages 50,000 designed peptides and 30 years of research to systematically develop targeted solutions that reduce aflatoxin contamination by 76-98% in crops.
Genvor's sustainable agricultural solutions help create a better tomorrow by reducing global crop losses and providing safer, biological alternatives to chemical pesticides for food production.
Genvor's AI platform designs peptides that can reduce fungal toxins in corn by up to 98%, using computational biology to revolutionize crop protection.
Found this article helpful?
Share it with your network and spread the knowledge!
Genvor Inc. has joined the B2i Digital platform as a Featured Company, marking a strategic move to expand investor engagement for its agricultural biotechnology innovations. The partnership comes at a pivotal time for Genvor as the company advances its AI-accelerated peptide design platform and sustainable crop-protection solutions. David Shapiro, CEO of B2i Digital, emphasized the growing demand for biological solutions in agriculture and Genvor's ability to meet that need through their specialized platform.
The significance of this announcement lies in addressing the massive $220 billion in annual global crop losses caused by plant pathogens. Genvor's proprietary BioCypher Algorithm leverages more than 50,000 designed peptides and over 30 years of foundational research to create targeted solutions for major agricultural challenges. The platform has demonstrated substantial efficacy, including 76%–98% reductions in total aflatoxin contamination in transgenic corn seeds across pathogens such as Aspergillus flavus and Fusarium species.
Chad Pawlak, CEO of Genvor, highlighted the company's accelerated momentum with recently issued patents, active partnership discussions, and a growing pipeline as key factors driving the need for expanded investor engagement. The company maintains a growing intellectual property portfolio, including two issued U.S. patents and one pending application covering 24 proprietary peptides. A significant milestone was achieved in November 2025 with the issuance of U.S. Patent No. 12,458,684 for transgenic corn expressing antifungal peptide AGM182, co-assigned to Genvor Inc. and the United States Department of Agriculture.
Genvor's development pipeline spans multiple crucial crops including corn, citrus, rice, soybeans, cotton, flax, and potato, with applications across both foliar spray solutions and seed traits. The company is currently engaged with major agricultural companies on joint venture evaluations and commercialization discussions, positioning its technology for broad market adoption. The licensing-first business model represents a strategic approach to integrating sustainable solutions within existing agricultural infrastructure while maintaining regulatory compliance.
The partnership with B2i Digital provides Genvor access to a proprietary network of more than 1.4 million market participants through multi-channel digital marketing and targeted outreach campaigns. This enhanced visibility comes at a critical juncture as global agriculture faces increasing pressure to adopt sustainable practices while maintaining crop yields. For more information about B2i Digital's platform and services, visit https://b2idigital.com. Additional details about Genvor's technology and development progress can be found at https://www.genvor.com.
Curated from NewMediaWire
